Post‐induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis

Abstract

Children starting IFX with severe UC showed lower post-induction TL and poor disease outcomes. Achieving adequate TL was associated with better efficacy outcomes.